is the definitive, gold-standard reference book for clinical guidelines, pathogen biology, and infectious disease management. Published by Elsevier and meticulously overhauled by a premier editorial team— Drs. Martin J. Blaser, Jeffrey I. Cohen, and Steven M. Holland —this 4,176-page, two-volume masterwork integrates clinical experience with cutting-edge science. It brings together the collective expertise of over 650 global authorities , establishing itself as an indispensable resource for infectious disease specialists, epidemiologists, clinicians, and medical libraries worldwide. The Evolution of a Medical Masterpiece
This section acts as a pharmacopeia for ID physicians.
Updated guidance on new antivirals for influenza, CMV, and Hepatitis B/C, as well as emerging vaccines for RSV and pneumococci.
A deep dive into localized and systemic infections, providing actionable clinical guidance on presentation, differential diagnosis, and management.
: Most hardcover purchases include an eBook version , allowing for offline reading, highlights, and smart study tools. Shopping Information is the definitive, gold-standard reference book for clinical
Many major international retailers also stock the 10th edition. Please note that availability can vary, so it's always best to check the seller's website directly for current stock.
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
: Instant access to the enhanced interactive version can be secured through VitalSource or RedShelf for approximately $401.99 USD. Final Verdict: Is It Worth It?
This section functions as an encyclopedia of pathogens. It is organized by type of organism. Blaser, Jeffrey I
: Dedicated strategies for clinicians navigating public health misinformation and crisis communication. Structural Breakdown of the Encyclopedia
: Henry Rutgers Chair of the Human Microbiome at Rutgers University and Director of the Center for Advanced Biotechnology and Medicine.
The textbook is organized into several sections, covering the principles of infectious disease management, including:
This edition integrates critical lessons from the post-pandemic era and advances in biotechnology: SARS-CoV-2/COVID-19: It brings together the collective expertise of over
For institutional buyers, academic clinicians, and students, the structural parameters of this text reinforce its massive scope:
The book maintains its comprehensive organizational structure, which is designed for both deep research and quick clinical reference:
For anyone who cares for patients with infectious diseases—whether in a university hospital, community clinic, or global health setting—this two‑volume set remains the indispensable resource. It is not merely a book; it is a living reference that will guide practice for the next five years and beyond.